263 related articles for article (PubMed ID: 28771721)
1. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
2. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
5. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
6. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
7. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
8. AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation.
Tian H; Lian R; Li Y; Liu C; Liang S; Li W; Tao T; Wu X; Ye Y; Yang X; Han J; Chen X; Li J; He Y; Li M; Wu J; Cai J
Nat Commun; 2020 Oct; 11(1):5127. PubMed ID: 33046716
[TBL] [Abstract][Full Text] [Related]
9. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
10. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial-mesenchymal transition in non-small cell lung cancer cells.
Li CH; Liu CW; Tsai CH; Peng YJ; Yang YH; Liao PL; Lee CC; Cheng YW; Kang JJ
Arch Toxicol; 2017 May; 91(5):2165-2178. PubMed ID: 27752740
[TBL] [Abstract][Full Text] [Related]
13. MDC1 promotes ovarian cancer metastasis by inducing epithelial-mesenchymal transition.
Liu X; Dong R; Jiang Z; Wei Y; Li Y; Wei L; Sun H; Li Y; Yang N; Yang Q; Liu Z; Kong B
Tumour Biol; 2015 Jun; 36(6):4261-9. PubMed ID: 25592380
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of CHIP promotes ovarian cancer metastasis by inducing Snail-mediated epithelial-mesenchymal transition.
Park SM; Park SH; Ryu KJ; Kim IK; Han H; Kim HJ; Kim SH; Hong KS; Kim H; Kim M; Cho BI; Heo JD; Kim NH; Hwang EM; Park JY; Yook JI; Cho HJ; Hwangbo C; Kim KD; Song H; Yoo J
Mol Oncol; 2019 May; 13(5):1280-1295. PubMed ID: 30927556
[TBL] [Abstract][Full Text] [Related]
15. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
Xie T; Tan M; Gao Y; Yang H
Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the recognition and degradation of host TRIM proteins by Salmonella effector SopA.
Fiskin E; Bhogaraju S; Herhaus L; Kalayil S; Hahn M; Dikic I
Nat Commun; 2017 Jan; 8():14004. PubMed ID: 28084320
[TBL] [Abstract][Full Text] [Related]
17. The human NANOS3 gene contributes to lung tumour invasion by inducing epithelial-mesenchymal transition.
Grelet S; Andries V; Polette M; Gilles C; Staes K; Martin AP; Kileztky C; Terryn C; Dalstein V; Cheng CW; Shen CY; Birembaut P; Van Roy F; Nawrocki-Raby B
J Pathol; 2015 Sep; 237(1):25-37. PubMed ID: 25904364
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
19. TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.
Chen Y; Zhao J; Li D; Hao J; He P; Wang H; Zhang M
Yonsei Med J; 2018 Jan; 59(1):43-50. PubMed ID: 29214775
[TBL] [Abstract][Full Text] [Related]
20. Deletion of SMURF 1 represses ovarian cancer invasion and EMT by modulating the DAB2IP/AKT/Skp2 feedback loop.
Fan X; Wang Y; Fan J; Chen R
J Cell Biochem; 2019 Jun; 120(6):10643-10651. PubMed ID: 30672020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
